Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A trial of intensity modulated radiation therapy for cervical cancer (INTERTECC)
This trial tried to find out more about a radiotherapy technique called intensity modulated radiation therapy (IMRT) alongside chemotherapy.
It was for women whose cancer has not spread to distant parts of the body.
More about this trial
Chemoradiotherapy is one of the usual treatments for cervical cancer. Radiotherapy has improved in recent years and for some cancers it is possible to shape the beam to the exact treatment area. So you might have fewer side effects. This technique is called intensity modulated radiotherapy (IMRT).
In this trial, researchers looked at a way of planning IMRT to see if it caused fewer side effects than the usual
The researchers thought that a scan called a PET-CT could help get better pictures of the area to be treated. This means the doctors could limit radiotherapy to the
One of the side effects the researchers looked at in detail, is a drop in the number of blood cells. Radiotherapy can affect the cells in the bone marrow that produce your blood cells. This is more likely if you are having treatment to the
The aims of the trial were to find out:
- how well IMRT works for cervical cancer
- if IMRT reduces side effects compared with usual radiotherapy
- more about how the treatment affects
quality of life
Summary of results
This trial didn't open in the UK. We don't plan to add a summary of the results.
How to join a clinical trial
UC San Diego
National Cancer Institute (NCI)